Mold Illness: Symptoms, Misconceptions, and Treatment
The clinical framework for diagnosing and treating mold illness and chronic inflammatory response syndrome (CIRS), including sequence, common misconceptions and the mistake most protocols make.
Every new patient arrives holding the same piece of paper, and somewhere in the first ten minutes they say a version of the same sentence. They have a positive urine mycotoxin test. Finally, they believe that everything now makes sense: the mast cell reactions, the exhaustion, the brain fog, the depression, the years of being told nothing was wrong. It must have been the mold all along!
But the test in their hands doesn’t say that.
A positive urine mycotoxin result tells you that mycotoxins are being excreted. It reflects recent or ongoing exposure, and it says nothing whatsoever about whether an immune system has been dysregulated by that exposure. A person with efficient detoxification pathways can test positive and be entirely well. A person with poor detoxification pathways can test for low urine levels while carrying a heavy intracellular mycotoxin load bound to DNA and cell walls. The test measures excretion, and excretion is not an illness.
Diagnosing mold illness off a positive mycotoxin test, and then putting a very ill patient onto a heavy binder protocol on the strength of it, is the most damaging intervention that I have witnessed in this field. I consider it medical malpractice. A patient deep into the cell danger response with a chronic inflammatory response syndrome (CIRS), who is given cholestyramine or Welchol too early does not get better; they get stripped of the lipids their cell membranes are built from, at the precise moment those membranes are the least able to spare them. The intervention arrives before the diagnosis has been earned, and the patient pays for the shortcut.
Mold rarely stays as just a mold problem. It is one of the triggers, often occurring alongside other conditions such as mast cell activation syndrome (MCAS), POTS and dysautonomia, Candida, hypermobility, heavy metal burden, tick-borne illness, retroviruses, mood disorders, and trauma responses. Mold and mycotoxins are direct mitochondrial poisons, disrupting the Krebs cycle and the electron transport chain, so the damage propagates outward from the cell’s power supply into whichever organ system was already closest to maximum mitochondrial heteroplasmy.
By the time such a patient reaches me, mast cells are firing indiscriminately, the autonomic nervous system is already highly dysregulated and any treatment aimed at only the mold issue without addressing the rest, destabilises them further until the downstream issues are sorted out first.
What follows in the article below covers:
The thirteen symptoms most commonly reported in mold illness, why they arrive as an incoherent list rather than a recognisable syndrome, and why that incoherence is the diagnostic signature itself rather than grounds for dismissing the patient who reports it.
Why the name is a misnomer, and what circulates in a water-damaged building alongside the fungi: the endotoxins, actinomycetes, beta glucans, hemolysins, and volatile organic compounds that make chronic inflammatory response syndrome a considerably broader problem than a mold count on a lab report can capture.
The genetics that decide who gets sick, why roughly three quarters of the people exposed to the same building clear these biotoxins without ever learning they were there, and what the remaining quarter’s immune systems fail to do that everyone else does automatically.
Why leaving the building, the one step almost everyone assumes is sufficient, so often fails to end the illness, and what carries on running an inflammatory cascade long after the exposure itself has gone.
The treatment sequence, from remediation and air filtration through MARCoNS testing, binders, and the hormonal and inflammatory markers worth correcting, including the one circumstance in which reaching for binders too early will make a very ill patient considerably worse.
Mold illness has two problems at once, and it falls into the gap between them: it is wildly over-diagnosed, because a cheap urine test hands anyone who takes the test a story that is often taken to explain all their symptoms. And it is poorly understood, because the same test tells you almost nothing about the actual illness. The article that follows fills in the gaps, covering everything about the misconceptions, diagnosis and treatment.
